← Leaderboards
Eliezer Masliah
University Of California San Diego
$24,264,295
Attributed
$24,264,295
Total exposure
27
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2005–18$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$24,264,295 · 27
By mechanism
P01$9,156,898 · 9
R01$8,704,221 · 4
R37$2,712,480 · 1
P30$1,996,858 · 4
P50$1,543,419 · 3
P41$150,419 · 6
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Nerve Degeneration”
- Paul S. Aisen · Cognition Therapeutics, Inc.$113,855,136
- Reisa A. Sperling · Banner Health$83,196,776
- Randall J Bateman · Washington University$83,099,227
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$76,236,227
- Jose A Luchsinger · Columbia University Health Sciences$75,117,371
- Keith A. Johnson · Banner Health$70,466,464
Research focus
Nerve DegenerationImmunocytochemistryProteinsNeuronsSynapsesIn VivoBrainFundingMediatingMolecularAlpha SynucleinAlzheimer&AposElectron MicroscopyPathway InteractionsCollaborationsTransgenic OrganismsNeuropathologyBehavioralBiochemicalPatternS DiseaseCellsProgramsResearch Personnel
Grant awards (102)
Neuropathology Core$282,088
P50 · FY2018 · AG · contact PI
Neuropathology Core$282,194
P50 · FY2017 · AG · contact PI
Neurobiology Core$122,596
P30 · FY2017 · MH · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$368,125
R01 · FY2016 · MH · contact PI
Neuropathology Core$268,376
P50 · FY2016 · AG · contact PI
Neurobiology Core$122,521
P30 · FY2016 · MH · contact PI
Neurobiology Core$1
P30 · FY2016 · MH · contact PI
Clearance Pathways in the CNS in Aging and HIV$375,875
R01 · FY2015 · AG · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$368,125
R01 · FY2015 · MH · contact PI
Neuropathology Core$261,853
P50 · FY2015 · AG · contact PI
Neurobiology Core (Page 498)$120,556
P30 · FY2015 · MH · contact PI
Clearance Pathways in the CNS in Aging and HIV$387,500
R01 · FY2014 · AG · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$368,125
R01 · FY2014 · MH · contact PI
a-Synuclein in Transgenic Models of MSA$304,381
P01 · FY2014 · NS · contact PI
a-synuclein clearance strategies for the treatment of Lewy body disease$292,403
R37 · FY2014 · AG · contact PI
Neuropathology Core$268,375
P50 · FY2014 · AG · contact PI
Neuropathology Core (UCSD)$188,640
P30 · FY2014 · NS · contact PI
Neurobiology Core (Page 498)$121,050
P30 · FY2014 · MH · contact PI
Clearance Pathways in the CNS in Aging and HIV$366,188
R01 · FY2013 · AG · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$353,400
R01 · FY2013 · MH · contact PI
a-Synuclein in Transgenic Models of MSA$332,409
P01 · FY2013 · NS · contact PI
a-synuclein clearance strategies for the treatment of Lewy body disease$300,751
R37 · FY2013 · AG · contact PI
NEUROPATHOLOGY AND NEUROSCIENCES$279,754
P01 · FY2013 · AG · contact PI
Neuropathology Core (UCSD)$265,977
P30 · FY2013 · NS · contact PI
Neurobiology Core (Page 498)$118,933
P30 · FY2013 · MH · contact PI
Clearance Pathways in the CNS in Aging and HIV$387,292
R01 · FY2012 · AG · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$367,828
R01 · FY2012 · MH · contact PI
a-synuclein clearance strategies for the treatment of Lewy body disease.$309,203
R37 · FY2012 · AG · contact PI
NEUROPATHOLOGY AND NEUROSCIENCES$295,996
P01 · FY2012 · AG · contact PI
a-Synuclein in Transgenic Models of MSA$266,613
P01 · FY2012 · NS · contact PI
Causes and Consequences of a-Synuclein Aggregation$218,914
P01 · FY2012 · AG · contact PI
Neuropathology Core (UCSD)$193,182
P30 · FY2012 · NS · contact PI
Neurobiology Core (Page 498)$123,284
P30 · FY2012 · MH · contact PI
Core D: Neuropathology and Animal Behavior$111,240
P01 · FY2012 · ES · contact PI
Neurobiology Core (Page 498)$10,000
P30 · FY2012 · MH · contact PI
Causes and Consequences of a-Synuclein Aggregation$441,013
P01 · FY2011 · AG · contact PI
a-Synuclein in Transgenic Models of MSA$351,369
P01 · FY2011 · NS · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$336,579
R01 · FY2011 · MH · contact PI
a-synuclein clearance strategies for the treatment of Lewy body disease.$316,725
R37 · FY2011 · AG · contact PI
NEUROPATHOLOGY AND NEUROSCIENCES$295,956
P01 · FY2011 · AG · contact PI
Neuropathology Core (UCSD)$222,398
P30 · FY2011 · NS · contact PI
Neurobiology Core (Page 498)$121,089
P30 · FY2011 · MH · contact PI
Core D: Neuropathology and Animal Behavior$100,169
P01 · FY2011 · ES · contact PI
THE HUNT FOR SYNAPTIC INTERACTORS OF ABETA$7,411
P41 · FY2011 · RR · contact PI
Causes and Consequences of a-Synuclein Aggregation$340,753
P01 · FY2010 · AG · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$340,343
R01 · FY2010 · MH · contact PI
NEUROPATHOLOGY AND NEUROSCIENCES$298,947
P01 · FY2010 · AG · contact PI
a-synuclein clearance strategies for the treatment of Lewy body disease.$291,477
R37 · FY2010 · AG · contact PI
Neprilysin Modification of Amyloid Professing in Models of AD$256,278
P01 · FY2010 · AG · contact PI
a-Synuclein in Transgenic Models of MSA$252,203
P01 · FY2010 · NS · contact PI
Core D: Neuropathology and Animal Behavior$93,059
P01 · FY2010 · ES · contact PI
NEUROBIOLOGY$537,325
P01 · FY2009 · DA · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$340,689
R01 · FY2009 · MH · contact PI
NEUROPATHOLOGY AND NEUROSCIENCES$338,123
P01 · FY2009 · AG · contact PI
Causes and Consequences of a-Synuclein Aggregation$326,227
P01 · FY2009 · AG · contact PI
Alpha-synuclein clearance strategies for the treatment of Lewy body disease$294,753
R37 · FY2009 · AG · contact PI
Core D: Neuropathology and Animal Behavior$102,268
P01 · FY2009 · ES · contact PI
MULTI-DISCIPLINARY APPROACHES FOR PRECLINICAL RESEARCH IN PARKINSONS DISEASE$38,960
P41 · FY2009 · RR · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$341,020
R01 · FY2008 · MH · contact PI
Causes and Consequences of a-Synuclein Aggregation$339,473
P01 · FY2008 · AG · contact PI
Alpha-synuclein clearance strategies for the treatment of Lewy body disease.$295,069
R37 · FY2008 · AG · contact PI
NEUROBIOLOGY$270,908
P01 · FY2008 · DA · contact PI
Core D: Neuropathology and Animal Behavior$124,996
P01 · FY2008 · ES · contact PI
MULTI-DISCIPLINARY APPROACHES FOR PRECLINICAL RESEARCH IN PARKINSONS DISEASE$24,390
P41 · FY2008 · RR · contact PI
CAUSES AND CONSEQUENCES OF ALPHA-SYNUCLEIN AGGREGATION$549,076
P01 · FY2007 · AG · contact PI
NEUROBIOLOGY$405,520
P01 · FY2007 · DA · contact PI
Mechanisms of Neuroprotection in HIV Encephalitis$379,260
R01 · FY2007 · MH · contact PI
Alpha-synuclein clearance strategies for the treatment of Lewy body disease.$301,398
R37 · FY2007 · AG · contact PI
MULTI-DISCIPLINARY APPROACHES FOR PRECLINICAL RESEARCH IN PARKINSONS DISEASE$27,134
P41 · FY2007 · RR · contact PI
CAUSES AND CONSEQUENCES OF ALPHA-SYNUCLEIN AGGREGATION$355,935
P01 · FY2006 · AG · contact PI
MECHANISMS OF FGF1 NEUROPROTECTION IN HIV ENCEPHALITIS$327,617
R01 · FY2006 · MH · contact PI
a-synuclein clearance strategies for the treatment of Lewy body disease.$310,701
R37 · FY2006 · AG · contact PI
LENTIVIRAL VECTORS FOR MODELING AND TREATMENT OF ALZHEIMER'S DISEASE IN TG MICE$273,724
P01 · FY2006 · AG · contact PI
NEUROBIOLOGY$232,128
P01 · FY2006 · DA · contact PI
CORRELATED IMAGING APPROACHES AND MULTISCALE DATABASES FOR RES IN PARKINSONS DI$14,249
P41 · FY2006 · RR · contact PI
MECHANISMS OF FGF1 NEUROPROTECTION IN HIV ENCEPHALITIS$335,502
R01 · FY2005 · MH
B-Synuclein as a Treatment for Lewy Body Disease$321,480
R01 · FY2005 · AG
NEUROBIOLOGY$238,315
P01 · FY2005 · DA
CORRELATED IMAGING APPROACHES AND MULTISCALE DATABASES FOR RES IN PARKINSONS DI$15,125
P41 · FY2005 · RR
MECHANISMS OF FGF1 NEUROPROTECTION IN HIV ENCEPHALITIS$335,502
R01 · FY2004 · MH
B-Synuclein as a Treatment for Lewy Body Disease$321,480
R01 · FY2004 · AG
IMAGING APPROACHES AND MULTISCALE DATABASES /PARKINSONS$23,150
P41 · FY2004 · RR
MECHANISMS OF FGF1 NEUROPROTECTION IN HIV ENCEPHALITIS$335,502
R01 · FY2003 · MH
B-Synuclein as a Treatment for Lewy Body Disease$321,480
R01 · FY2003 · AG
MECHANISMS OF FGF1 NEUROPROTECTION IN HIV ENCEPHALITIS$348,502
R01 · FY2002 · MH
B-Synuclein as a Treatment for Lewy Body Disease$321,480
R01 · FY2002 · AG
NEUROBIOLOGY CORE$266,631
P30 · FY2002 · MH
LENTIVIRAL VECTORS FOR MODELING AND TREATMENT OF ALZHEIMER'S DISEASE IN TG MICE$243,200
P01 · FY2002 · AG
NeuroAIDS: Neuropathology$124,146
P01 · FY2002 · DA
NACP/ALPHA SYNUCLEIN &DEGERATION IN LEWY BODY$0
P50 · FY2002 · AG
B-Synuclein as a Treatment for Lewy Body Disease$321,480
R01 · FY2001 · AG
BASIS OF SYNAPTIC PATHOLOGY IN ALZHEIMERS DISEASE$169,391
R01 · FY2001 · AG
NeuroAIDS: Neuropathology$124,146
P01 · FY2001 · DA
NACP/ALPHA SYNUCLEIN &DEGERATION IN LEWY BODY$0
P50 · FY2001 · AG
NEUROBIOLOGY CORE$0
P30 · FY2001 · MH
NeuroAIDS: Neuropathology$208,188
P01 · FY2000 · DA
CORE--NEUROPATHOLOGY$171,293
P50 · FY2000 · MH
BASIS OF SYNAPTIC PATHOLOGY IN ALZHEIMERS DISEASE$164,456
R01 · FY2000 · AG
NeuroAIDS: Neuropathology$124,146
P01 · FY2000 · DA
NACP/ALPHA SYNUCLEIN &DEGERATION IN LEWY BODY$9,240
P50 · FY2000 · AG
NACP/ALPHA SYNUCLEIN &DEGERATION IN LEWY BODY$0
P50 · FY2000 · AG
NACP/ALPHA SYNUCLEIN &DEGERATION IN LEWY BODY$0
P50 · FY2000 · AG